I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Callendret, Benoit
95
results:
Search for persons
X
Format
Online (95)
Mediatypes
Articles (Online) (42)
OpenAccess-fulltext (53)
Languages
english (91)
french (1)
Sorted by: Relevance
Sorted by: Year
?
1
A Randomized, Double‐Blind, Placebo‐Controlled, Phase 1 Stu..:
Eto, Takashi
;
Okubo, Yusuke
;
Momose, Atsushi
...
Influenza and Other Respiratory Viruses. 18 (2024) 6 - p. , 2024
Link:
https://doi.org/10.1111/..
?
2
Immunogenicity, safety and reactogenicity of Ad26.RSV.preF/..:
Jastorff, Archana
;
Bastian, Arangassery Rosemary
;
Ligtenberg, Nynke
...
Human Vaccines & Immunotherapeutics. 20 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1080/..
?
3
A Phase 1/2a Study Evaluating Safety and Immunogenicity of ..:
Langley, Joanne M
;
Nolan, Terry M
;
Rämet, Mika
...
Open Forum Infectious Diseases. , 2024
Link:
https://doi.org/10.1093/..
?
4
Long-term efficacy and immunogenicity of Ad26.RSV.preF–RSV ..:
Falsey, Ann R
;
Hosman, Tessa
;
Bastian, Arangassery Rosemary
...
The Lancet Infectious Diseases. , 2024
Link:
https://doi.org/10.1016/..
?
5
Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein..:
Hosman, Tessa
;
van Heesbeen, Roy
;
Bastian, Arangassery Rosemary
...
Human Vaccines & Immunotherapeutics. 20 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1080/..
?
6
Evaluation of symptoms in respiratory syncytial virus infec..:
Osborne, Richard H.
;
Nelson, Lauren M.
;
Fehnel, Sheri
...
Journal of Patient-Reported Outcomes. 7 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
7
Concomitant Administration of Ad26.RSV.preF/RSV preF Protei..:
Widagdo, Widagdo
;
Bastian, Arangassery Rosemary
;
Jastorff, Archana M
...
The Journal of Infectious Diseases. 230 (2023) 2 - p. e374-e383 , 2023
Link:
https://doi.org/10.1093/..
?
8
Combination Ad26.RSV.preF/preF protein vaccine induces supe..:
Saeland, Eirikur
;
van der Fits, Leslie
;
Bolder, Renske
...
npj Vaccines. 8 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
9
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A an..:
Cox, Freek
;
Saeland, Eirikur
;
Thoma, Anne
...
Vaccines. 11 (2023) 3 - p. 672 , 2023
Link:
https://doi.org/10.3390/..
?
10
Persistence of immunological memory as a potential correlat..:
McLean, Chelsea
;
Dijkman, Karin
;
Gaddah, Auguste
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
11
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.p..:
Comeaux, Christy A
;
Bart, Stephan
;
Bastian, Arangassery Rosemary
...
The Journal of Infectious Diseases. 229 (2023) 1 - p. 19-29 , 2023
Link:
https://doi.org/10.1093/..
?
12
Vaccine-induced antibody Fc-effector functions in humans im..:
Bartsch, Yannic C.
;
Cizmeci, Deniz
;
Yuan, Dansu
...
Journal of Virology. 97 (2023) 11 - p. , 2023
Link:
https://doi.org/10.1128/..
?
13
Burden of Respiratory Syncytial Virus–Associated Acute Resp..:
Kenmoe, Sebastien
;
Chu, Helen Y
;
Dawood, Fatimah S
...
The Journal of Infectious Diseases. 229 (2023) Supplement_1 - p. S51-S60 , 2023
Link:
https://doi.org/10.1093/..
?
14
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Ve..:
Stuart, Arabella S V
;
Virta, Miia
;
Williams, Kristi
...
The Journal of Infectious Diseases. 227 (2022) 1 - p. 71-82 , 2022
Link:
https://doi.org/10.1093/..
?
15
First-in-human study to evaluate safety, tolerability, and ..:
Bockstal, Viki
;
Shukarev, Georgi
;
McLean, Chelsea
...
PLOS ONE. 17 (2022) 10 - p. e0274906 , 2022
Link:
https://doi.org/10.1371/..
1-15